Advertisement
In most cases, children under 18 and pregnant women should not receive the melanoma drug Yervoy (ipilimumab). The drug has not been studied or approved in these groups, and preliminary research shows that Yervoy could be dangerous to a developing fetus. Consult your doctor: He or she may still prescribe the drug if it is your best option.
Continue Learning about Pharmacology
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.